We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+11.22%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$347B
AUM Growth
+$49B
Cap. Flow
+$12.7B
Cap. Flow %
3.67%
Top 10 Hldgs %
25.82%
Holding
11,328
New
1,232
Increased
3,827
Reduced
4,449
Closed
1,709

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$1.33B
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$781M
3
TSLA icon
Tesla
TSLA
+$468M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$467M
5
HD icon
Home Depot
HD
+$344M

Sector Composition

Rank Sector Weight
1 Technology 2.2%
2 Consumer Discretionary 1.94%
3 Communication Services 1.89%
4 Healthcare 1.12%
5 Financials 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BVXVW
9276
DELISTED
BiondVax Pharmaceuticals Ltd.
BVXVW
$55K ﹤0.01%
21,231
-1,483
-7% -$1.97K
NAVB
9277
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$55K ﹤0.01%
43,900
+25,700
+141% +$22.2K
LCTX icon
9278
Lineage Cell Therapeutics
LCTX
$286M
$53K ﹤0.01%
59,291
-7,029
-11% -$5.86K
XNET
9279
Xunlei
XNET
$323M
$53K ﹤0.01%
10,761
-27,337
-72% -$119K
ASXC
9280
DELISTED
Asensus Surgical, Inc.
ASXC
$53K ﹤0.01%
35,717
-21,040
-37% -$73.1K
ALYA
9281
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$53K ﹤0.01%
+18,733
New +$50K
IMDX
9282
Insight Molecular Diagnostics
IMDX
$145M
$52K ﹤0.01%
1,166
-897
-43% -$32.4K
RIGL icon
9283
PUT
Rigel Pharmaceuticals
RIGL
$873M
$52K ﹤0.01%
2,420
+230
+11% +$4.74K
TRAK icon
9284
PUT
ReposiTrak
TRAK
$147M
$52K ﹤0.01%
10,300
-1,600
-13% -$8.22K
UUUU icon
9285
CALL
Energy Fuels
UUUU
$3.99B
$52K ﹤0.01%
27,200
-45,600
-63% -$89.7K
ITI
9286
DELISTED
Iteris, Inc.
ITI
$52K ﹤0.01%
10,508
-14,885
-59% -$75.8K
APTX
9287
DELISTED
Aptinyx Inc. Common Stock
APTX
$52K ﹤0.01%
+15,274
New +$52.6K
JRJC
9288
DELISTED
China Finance Online Co., Ltd.
JRJC
$52K ﹤0.01%
5,895
+3,652
+163% +$24.8K
LSTA icon
9289
Lisata Therapeutics
LSTA
$15.7M
$51K ﹤0.01%
+1,363
New +$49K
ACTG icon
9290
PUT
Acacia Research
ACTG
$439M
$50K ﹤0.01%
+18,900
New +$51.8K
ADMA icon
9291
PUT
ADMA Biologics
ADMA
$2.18B
$50K ﹤0.01%
12,400
-12,600
-50% -$54.9K
AXTI icon
9292
AXT Inc
AXTI
$4.42B
$50K ﹤0.01%
11,594
-14,721
-56% -$47.3K
CYCN icon
9293
Cyclerion Therapeutics
CYCN
$18.7M
$50K ﹤0.01%
912
+386
+73% +$36K
IAG icon
9294
CALL
IAMGOLD
IAG
$12.7B
$50K ﹤0.01%
13,300
-24,300
-65% -$86K
CASA
9295
CALL
DELISTED
Casa Systems, Inc. Common Stock
CASA
$50K ﹤0.01%
12,300
-7,400
-38% -$35.3K
HZN
9296
DELISTED
Horizon Global Corporation
HZN
$50K ﹤0.01%
+14,272
New +$52.8K
CAAS icon
9297
CALL
China Automotive Systems
CAAS
$161M
$49K ﹤0.01%
+15,600
New +$40.9K
CPRX
9298
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
$49K ﹤0.01%
13,000
-61,300
-83% -$287K
HNRG icon
9299
Hallador Energy
HNRG
$771M
$49K ﹤0.01%
+16,342
New +$50.2K
VEON icon
9300
VEON
VEON
$4.29B
$49K ﹤0.01%
781
-359
-31% -$22.1K

Similar funds

Jeff Yass's Q4 2019 Portfolio in Review

As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass deployed $12.7B of net new capital in Q4 2019, opening 1,232 new positions and adding to 3,827 existing holdings. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 2.2% of assets, up from 2.1% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Amazon, an estimated $1.36B trimmed.

  • Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
  • Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
  • Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
  • Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
  • Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
  • Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
  • Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.

Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.